These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 34539894)
1. Weekly versus triweekly cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma: a systematic review and pooled analysis. Tang J; Zou GR; Li XW; Su Z; Cao XL; Wang BC J Cancer; 2021; 12(20):6209-6215. PubMed ID: 34539894 [No Abstract] [Full Text] [Related]
2. Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy. Li X; Li L; Sun R; Gao J; Li Z; Xue Y; Zhu L; Xu T; Sun C; Xi Y; Xiong W Eur J Med Res; 2023 Oct; 28(1):399. PubMed ID: 37794519 [TBL] [Abstract][Full Text] [Related]
3. Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma. Wang K; Dong J; He S; Wang X; Jiang C; Hu P; Guo J; Cai X; Wang X BMC Cancer; 2019 May; 19(1):482. PubMed ID: 31117967 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of weekly versus triweekly cisplatin treatment concomitant with radiotherapy for locally advanced nasopharyngeal carcinoma: A systematic review and pooled analysis. Tian X; Zhu Q; Zhang Z Front Pharmacol; 2022; 13():999027. PubMed ID: 36686714 [No Abstract] [Full Text] [Related]
5. Efficacy and safety of weekly versus triweekly cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma: A meta-analysis. Chen L; Li YC; Hu M; Zhao SJ; Yang QW Medicine (Baltimore); 2022 Dec; 101(52):e31842. PubMed ID: 36596073 [TBL] [Abstract][Full Text] [Related]
6. The evidence on effectiveness of weekly vs triweekly cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC): a systematic review and meta-analysis. Jacinto JK; Co J; Mejia MB; Regala EE Br J Radiol; 2017 Nov; 90(1079):20170442. PubMed ID: 29053029 [TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis. Zhou R; Zhu J; Chen X; Liu Y; Wang Y; Zhang T Clin Transl Oncol; 2020 Mar; 22(3):429-439. PubMed ID: 31165410 [TBL] [Abstract][Full Text] [Related]
8. A Systematic Review and Meta-Analysis of Studies Comparing Concurrent Chemoradiotherapy With Radiotherapy Alone in the Treatment of Stage II Nasopharyngeal Carcinoma. Xu YC; Chen KH; Liang ZG; Zhu XD Front Oncol; 2022; 12():843675. PubMed ID: 35903695 [TBL] [Abstract][Full Text] [Related]
9. The effect of adjuvant chemotherapy on survival in patients with residual nasopharyngeal carcinoma after undergoing concurrent chemoradiotherapy. Yang S; Lin S; Fu Q; Cai B; Kong F; Huang G; Li F; Wang H PLoS One; 2015; 10(3):e0120019. PubMed ID: 25799566 [TBL] [Abstract][Full Text] [Related]
10. Weekly versus triweekly cisplatin plus intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity score analysis with a large cohort. Zhu Q; Hu H; Tang LQ; You R; Zhao JJ; Weng DS; Pan QZ; Chen CL; Zhou ZQ; Tang Y; Xia JC J Cancer; 2018; 9(19):3447-3455. PubMed ID: 30310501 [No Abstract] [Full Text] [Related]
11. Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis. Mohamed A; Twardy B; Zordok MA; Ashraf K; Alkhoder A; Schrapp K; Steuer C; Chen Z; Pakkala S; Pillai R; Trad Wadsworth J; Higgins K; Beitler JJ; Ramalingam SS; Owonikoko TK; Khuri FR; Shin DM; Behera M; Saba NF Head Neck; 2019 May; 41(5):1490-1498. PubMed ID: 30835900 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial. Cao SM; Yang Q; Guo L; Mai HQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Qiu F; Sun R; Chen QY; Huang PY; Luo DH; Hua YJ; Wu YS; Lv X; Wang L; Xia WX; Tang LQ; Ye YF; Chen MY; Guo X; Hong MH Eur J Cancer; 2017 Apr; 75():14-23. PubMed ID: 28214653 [TBL] [Abstract][Full Text] [Related]
13. Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis. Liao JF; Zhang Q; Du XJ; Lan M; Liu S; Xia YF; Cai XY; Luo W Cancer Commun (Lond); 2019 Jun; 39(1):40. PubMed ID: 31248459 [TBL] [Abstract][Full Text] [Related]
14. Concurrent chemoradiotherapy with additional chemotherapy for nasopharyngeal carcinoma: A pooled analysis of propensity score-matching studies. Li M; Zhang B; Chen Q; Zhang L; Mo X; Chen Z; Jin Z; Chen L; You J; Zhang S Head Neck; 2021 Jun; 43(6):1912-1927. PubMed ID: 33644916 [TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial. Yang Q; Cao SM; Guo L; Hua YJ; Huang PY; Zhang XL; Lin M; You R; Zou X; Liu YP; Xie YL; Wang ZQ; Mai HQ; Chen QY; Tang LQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Li JB; Ling L; Guo X; Hong MH; Chen MY Eur J Cancer; 2019 Sep; 119():87-96. PubMed ID: 31425966 [TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of weekly cisplatin versus three weekly cisplatin chemotherapy plus concurrent radiotherapy (CRT) for advanced head and neck cancer (HNC). Guan J; Zhang Y; Li Q; Zhang Y; Li L; Chen M; Xiao N; Chen L Oncotarget; 2016 Oct; 7(43):70185-70193. PubMed ID: 27602493 [TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study. Guo SS; Tang LQ; Chen QY; Zhang L; Liu LT; Guo L; Mo HY; Luo DH; Huang PY; Xiang YQ; Sun R; Chen MY; Wang L; Lv X; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ Oncotarget; 2016 May; 7(20):29739-48. PubMed ID: 27105538 [TBL] [Abstract][Full Text] [Related]
18. Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02). Lee JY; Sun JM; Oh DR; Lim SH; Goo J; Lee SH; Kim SB; Park KU; Kim HK; Hong DS; Kim JS; Kim SG; Yi SY; Yun HJ; Hyun MS; Kim HJ; Jung SH; Park K; Ahn YC; Ahn MJ Radiother Oncol; 2016 Feb; 118(2):244-50. PubMed ID: 26705681 [TBL] [Abstract][Full Text] [Related]
19. Retrospective Analysis of Concurrent Chemoradiation with Triweekly Cisplatin plus 5-Fluorouracil Versus Weekly Cisplatin in Cervical Cancer. Sonoda K; Yahata H; Ichinoe A; Okugawa K; Kaneki E; Kawano Y; Kenjo H; Ohgami T; Yagi H; Ohga S; Asai K; Nakamura K; Honda H; Kato K Anticancer Res; 2015 Jun; 35(6):3447-54. PubMed ID: 26026109 [TBL] [Abstract][Full Text] [Related]
20. A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study. Meng DF; Sun R; Peng LX; Huang YS; Yang Q; Luo DH; Hu WH; Xie FY; Luo W; Zhao C; Guo L; Mai HQ; Chen MY; Xie P; Zheng LS; Yang JP; Mei Y; Qiang YY; Xu L; Li CZ; Huang BJ; Qian CN; Sun R J Cancer; 2018; 9(1):92-99. PubMed ID: 29290773 [No Abstract] [Full Text] [Related] [Next] [New Search]